In agreement with this, previous research papers have also portrayed the absence of hPL in breast cancer patients [20], with one study confirming that out of 54 infiltrating ductal breast carcinomas, none contained hPL [21]. This evidence concerns the gene LGALS1 and invasive ductal breast carcinoma.